Procurement of Inj. Recombinant IGF-1 for AIIMS New Delhi

Work Description - Purchase Of Inj. Recombinant Igf-1

The All India Institute of Medical Science-New Delhi (AIIMS New Delhi) invites eligible bidders for an Open Tender (Reference No. 11/H/Inj. Recombinant IGF-1/2026-27) for the 'Purchase of Inj. Recombinant IGF-1'. This procurement, categorized as Goods and specifically Drugs and Pharmaceutical Products, will follow a two-cover bidding system. Key critical dates for this tender include e-publication, document download, and bid submission commencing on June 25, 2026, at 12:00 PM. The final deadline for document download and bid submission is July 16, 2026, at 12:00 PM, with bids scheduled for opening on July 17, 2026, at 12:00 PM at the Main Hospital Store, AIIMS New Delhi. A mandatory Earnest Money Deposit (EMD) of ₹50,000 is required, payable to 'AIIMS Main Grant' at New Delhi, with provisions for EMD exemption through Bank Guarantee or ST. There is no tender fee associated with this bid. The successful bidder will be expected to complete the work within 45 days, and all submitted bids will remain valid for 270 days from the bid opening date. Prospective bidders are advised to thoroughly review the complete tender documents for detailed specifications and terms.